Sage Therapeutics, Inc. (SAGE) Social Stream



Sage Therapeutics, Inc. (SAGE): $45.72

1.56 (+3.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SAGE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SAGE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 20 $105 $48 $73.368 $44.59 64.54%
2021-12-20 19 $105 $48 $72.842 $44.59 63.36%
2022-01-12 19 $105 $48 $73.157 $44.59 64.07%
2022-01-26 17 $105 $48 $73.157 $44.59 64.07%
2022-02-16 17 $105 $48 $72.315 $44.59 62.18%
2022-02-25 18 $105 $48 $71.736 $44.59 60.88%
2022-02-28 17 $105 $48 $70.055 $44.59 57.11%
2022-03-21 17 $105 $40 $68.722 $44.59 54.12%
2022-04-01 18 $105 $37 $67.052 $44.59 50.37%
2022-05-03 18 $105 $37 $67.21 $44.59 50.73%
2022-05-04 18 $105 $37 $65.7 $44.59 47.34%
2022-05-06 18 $105 $37 $64.631 $44.59 44.95%
2022-05-10 18 $105 $37 $64.421 $44.59 44.47%
2022-05-24 19 $105 $37 $64.85 $44.59 45.44%
2022-06-01 19 $105 $37 $65 $44.59 45.77%
2022-06-13 19 $105 $36 $64.2 $44.59 43.98%
2022-07-21 18 $105 $36 $61 $44.59 36.8%
2022-08-03 18 $105 $36 $57.941 $44.59 29.94%
2022-08-04 18 $105 $36 $59.611 $44.59 33.69%
2022-09-19 18 $105 $36 $59.5 $44.59 33.44%
2022-10-17 16 $105 $36 $59.5 $44.59 33.44%
2022-11-01 17 $105 $36 $58.526 $44.59 31.25%
2022-11-08 17 $105 $36 $59.111 $44.59 32.57%
2022-11-11 18 $105 $36 $57 $44.59 27.83%
2022-11-21 19 $105 $36 $56.85 $44.59 27.49%
2022-12-07 20 $105 $36 $55 $44.59 23.35%
2023-01-25 20 $105 $36 $55.3 $44.59 24.02%

The Trend in the Analyst Price Target


Over the past 35 weeks, SAGE's average price target has gone down $9.55.

SAGE reports an average of 71.82% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-01 19 105 36 64.20 34.24 87.5%
2022-07-21 18 105 36 61.00 35.58 71.44%
2022-08-10 18 105 36 59.50 42.84 38.89%
2022-10-17 17 105 36 59.50 38.07 56.29%
2022-11-21 19 105 36 56.85 35.05 62.2%

SAGE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.15 8 1 11 0 0 20

The Trend in the Broker Recommendations


Over the past 13 months, SAGE's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SAGE as an investment opportunity.

  • SAGE THERAPEUTICS INC's number of analysts covering the stock is higher than 3471.23% of all US stocks.
  • In terms of how SAGE THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3223.02% of that group.
  • In terms of how SAGE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 2910.06% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAGE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1083.32% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SAGE THERAPEUTICS INC are RCKT, FGEN, and XENE.

Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6913 seconds.